Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1394studies shown
Showing 801-825 of 1,394
CompletedNCT03822416

Treating Smokers With Mental Illness

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Depression
CompletedNCT02974010

Sequential Therapy for the Treatment of Severe Depression in bipolarity.

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can better prevent setbacks and support longer-term stability.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
NeuroRx, Inc.
Condition
Depression
CompletedNCT03918954

Comparison of Physical and Virtual Sensory Room in an Inpatient Setting

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

DepressionOtherOver 18 Years
Countries
Sweden
Sponsor
Vastra Gotaland Region
Condition
Depression
CompletedNCT00666432

Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 15 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT01948024

Bio-equivalence Study Between SAPHRIS and Asenapine

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
Sun Pharmaceutical Industries Limited
Condition
Schizophrenia
CompletedNCT03658824

Behavioural Activation for Depression in bipolarity: A Case Series

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
University of Exeter
Condition
Depression
CompletedNCT04855409

Neuronal Integrity in Depression in bipolarity

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 65 Years
Countries
Global
Sponsor
Mehmet Diyaddin Güleken
Condition
Depression
CompletedNCT03404882

Peer Support Experience for Patients Discharged From Acute Psychiatric Care

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Alberta
Condition
Schizophrenia
CompletedNCT00312494

3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects

This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
CompletedNCT00282464

A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Depression
TerminatedNCT00329108

Ziprasidone And Olanzapine's Outcomes In Mania

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Germany, Greece, Italy, Spain, Turkey
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
CompletedNCT03050853

The Appeal and Impact of E-cigarettes in Smokers With SMI

This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia
CompletedNCT00141271

A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Depression
CompletedNCT00265330

Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolarity I (Manic or Mixed)

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

BipolarityOtherFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
CompletedNCT00280566

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolarity I (Manic or Mixed)

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

BipolarityOtherOver 18 Years
Countries
Chile, France, Germany, Guatemala, China, India, Italy, Mexico, Russian Federation, Spain, Taiwan, United States, Venezuela
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
TerminatedNCT00055575

Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
TerminatedNCT03562520

Toward Exercise as Medicine for Adolescents With Bipolarity

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 13 Years to 21 Years
Countries
Canada
Sponsor
Sunnybrook Health Sciences Centre
Condition
Bipolarity
CompletedNCT01431573

Wake Therapy in the Treatment of Depression

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.

DepressionOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Depression
CompletedNCT00483548

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

DepressionOtherOver 18 Years
Countries
Australia, India, United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Depression
CompletedNCT01053429

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOther
Countries
Global
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
TerminatedNCT01113541

One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome

This study exists to explore whether the medication Oral could improve care and understanding. Researchers are trying to understand how people respond to the medication Oral in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
WithdrawnNCT03764683

Suvorexant (Belsomra) for the Treatment of Depression in bipolarity With Insomnia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

DepressionOtherFrom 18 Years to 75 Years
Countries
Global
Sponsor
Massachusetts General Hospital
Condition
Depression
WithdrawnNCT01124877

Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolarity I (Manic Or Mixed)

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

BipolarityOtherFrom 10 Years to 17 Years
Countries
Global
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity